Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy

BACKGROUND: Checkpoint inhibitors provided sustained clinical benefit to metastatic lung cancer patients. Nonetheless, prognostic markers in metastatic settings are still under research. Imaging offers distinctive advantages, providing whole-body information non-invasively, while routinely available...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Oncol
Glavni autori: Trebeschi, Stefano, Bodalal, Zuhir, Boellaard, Thierry N., Tareco Bucho, Teresa M., Drago, Silvia G., Kurilova, Ieva, Calin-Vainak, Adriana M., Delli Pizzi, Andrea, Muller, Mirte, Hummelink, Karlijn, Hartemink, Koen J., Nguyen-Kim, Thi Dan Linh, Smit, Egbert F., Aerts, Hugo J. W. L., Beets-Tan, Regina G. H.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7962549/
https://ncbi.nlm.nih.gov/pubmed/33738253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.609054
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items